| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-08 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 7e-08 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |